Lamivudine, Zidovudine Oral Tablet 150-300Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Lamivudine, Zidovudine: Oral tablet (150-300mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Lamivudine/Zidovudine Tablet
Drug Image file DrugItem_15199.JPG
Lamivudine/Zidovudine Tablet
Teva Pharmaceuticals USA Inc
Pill Identification: TV TV  |  L2 L2
Drug Image file DrugItem_19049.JPG
Lamivudine/Zidovudine Tablet
Aurobindo Pharma USA Inc.
Pill Identification: J 58 

What is this Medicine?

LAMIVUDINE; ZIDOVUDINE (la MI vyoo deen; zye DOE vyoo deen) is two antiretroviral medicines in one tablet. It is used with other medicines to treat HIV. This medicine is not a cure for HIV. It will not stop the spread of HIV to others.

Similar Brand Name Drugs : Combivir: Oral tablet (150-300mg)
CVS Pharmacy Patient Statistics for Lamivudine, Zidovudine: Oral tablet(150-300mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Lamivudine and Zidovudine 150mg-300mg Tablet

NDC: 681800284
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Human Immunodeficiency Virus (HIV) Infection

Sometimes used for but not FDA approved for the following conditions:
Human Immunodeficiency Virus (HIV) Prophylaxis

Storage Information
Protect from moisture
Store between 36 to 86 degrees F
Lamivudine and Zidovudine 150mg-300mg Tablet

Reported Side Effects for Lamivudine and Zidovudine 150mg-300mg Tablet

Inflamed Pancreas Incidence:
0.3%*
Severity: SEVERE
Onset: DELAYED
Low Platelet Count Incidence:
0.4%*
Severity: MODERATE
Onset: DELAYED
High Bilirubin Level Incidence:
0.8%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
1.7-3.7%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
2.9%*
Severity: MODERATE
Onset: DELAYED
High Amylase Levels Incidence:
4.2%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cells Incidence:
7.2%*
Severity: MODERATE
Onset: DELAYED
Muscle Pain Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
9.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
10.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Chills Incidence:
10.0%*
Severity: MILD
Onset: RAPID
Inability To Sleep Incidence:
11.0%*
Severity: MILD
Onset: EARLY
Muscle And/Or Bone Pain Incidence:
12.0%*
Severity: MILD
Onset: EARLY
Nerve Pain Incidence:
12.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
13.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
18.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
18.0%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
27.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
27.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
33.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
35.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Lamivudine and Zidovudine 150mg-300mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Marijuana and Lamivudine and Zidovudine 150mg-300mg Tablet(Lamivudine)
Marijuana and Nucleoside reverse transcriptase inhibitors(Lamivudine)
Although an interaction is possible, these drugs may be used together. In therory, side effects from Marijuana, Medical may get worse if you take Anti-retroviral nucleoside reverse transcriptase inhibitors (NRTIs). However, the importance of this interaction is not known. Notify your health care provider if you notice increased fatigue, nausea, vomiting, or any other unusual effects.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Lamivudine, Zidovudine

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5